Sensitivity and specificity of urinary cannabinoid detection with two immunoassays after controlled oral administration of cannabinoids to humans

Therapeutic Drug Monitoring

Volumn 30, Issue 4, 2008, Pages 530-535

  Grauwiler, Sandra B ^a   Drewe, Jürgen ^a   Scholer, André ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

11 nor delta9 tetrahydrocannabinol 9 carboxylic acid; Immunoassays; LC MS MS; Sensitivity; Specificity

Indexed keywords

CANNABIS; DRONABINOL; CANNABINOID; PLANT EXTRACT; PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL;

ARTICLE; CLONED ENZYME DONOR IMMUNOASSAY; DRUG DETERMINATION; DRUG URINE LEVEL; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; OPEN STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD; URINALYSIS; ADULT; CALIBRATION; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; ORAL DRUG ADMINISTRATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; ROC CURVE; SOLUTION AND SOLUBILITY; TANDEM MASS SPECTROMETRY; URINE;

ADMINISTRATION, ORAL; ADULT; CALIBRATION; CANNABINOIDS; CANNABIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS REACTIONS; HUMANS; HYDROLYSIS; IMMUNOASSAY; MALE; PLANT EXTRACTS; PSYCHOTROPIC DRUGS; QUALITY CONTROL; REFERENCE STANDARDS; ROC CURVE; SOLUTIONS; TANDEM MASS SPECTROMETRY; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 58149107959     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318180c7c2     Document Type: Article

References (10)

1. Grauwiler SB, Scholer A. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850:515-522.
2. Eskridge KD, Guthrie SK. Clinical issues associated with urine testing of substances of abuse. Pharmacotherapy. 1997;17:497-510.
3. Zacher JL, Givone DM. False-positive urine opiate screening associated with fluoroquinolone use. Ann Pharmacother. 2004;38:1525-1528.
4. Lehrer M. The role of gas chromatography/mass spectrometry. Instrumental techniques in forensic urine drug testing. Clin Lab Med. 1998; 18:631-649.
5. Alessio L, Berlin A. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health. 1985;55:99-106.
6. Huestis MA, Henningfield JE. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THC-COOH during and after smoking marijuana. J Anal Toxicol. 1992;16:276-282.
7. Huestis MA, Henningfield JE. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH). J Anal Toxicol. 1992;16:283-290.
8. Huestis MA. Urinary excretion half-life of 11-nor-9-carboxy-delta9- tetrahydrocannabinol in humans. Ther Drug Monit. 1998;20:570-576.
9. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [erratum appears in Clin Chem. 1993;39:1589]. Clin Chem. 1993;39:561-577.
10. Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology. 2003;229:3-8.